Therapy of diabetes and dyslipidemia in acromegaly.

Role of Insulin Resistance in Human Disease

Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154 · see citing works

Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease

DeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,555 · see citing works

Acute and Chronic Effect of Insulin on Leptin Production in Humans: Studies In Vivo and In Vitro

Kolaczynski, J. W., Nyce, M. R., Considine, R. V., Boden, G., Nolan, J. J., Henry, R., Mudaliar, S. R., Olefsky, J., & Caro, J. F. (1996) · Diabetes · doi:10.2337/diab.45.5.699 · Cited by 700 · see citing works

An audit of outcome of treatment in acromegaly

Bates, A. S., HOFF, W. V., JONES, J. M., & CLAYTON, R. N. (1993) · QJM · doi:10.1093/oxfordjournals.qjmed.a068816 · Cited by 470 · see citing works

ACROMEGALY

Nabarro, J. D. N. (1987) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1987.tb00805.x · Cited by 443 · see citing works

Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM

Malmström, R., Taskinen, M., Karonen, S. ‐., & Yki‐Järvinen, H. (1996) · Diabetologia · doi:10.1007/bf00403921 · Cited by 247 · see citing works

Long-term Treatment of 189 Acromegalic Patients With the Somatostatin Analog Octreotide

Vance, M. L. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400080073013 · Cited by 237 · see citing works

Treatment of Acromegaly with Dopamine Agonists

Jaffe, C. A., & Barkan, A. L. (1992) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30210-x · Cited by 222 · see citing works

Hormonal and Metabolic Effects of Radiotherapy in Acromegaly: Long-Term Results in 128 Patients Followed in a Single Center

Barrande, G., Pittino-Lungo, M., Coste, J., Ponvert, D., BERTAGNA, X. Y., LUTON, J. P., & Bertherat, J. Y. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.10.6870 · Cited by 215 · see citing works

Insulin resistance in acromegaly: defects in both hepatic and extrahepatic insulin action

Hansen, I. B., Tsalikian, E., Beaufrère, B., Gerich, J. E., Haymond, M. W., & Rizza, R. A. (1986) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1986.250.3.e269 · Cited by 214 · see citing works

Three Year Follow-Up of Acromegalic Patients Treated with Intramuscular Slow-Release Lanreotide1

Caron, P. J., Morange, I., Cogne, M., & Jaquet, P. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.1.3714 · Cited by 179 · see citing works

Sandostatin LAR in Acromegalic Patients: Long Term Treatment

Fløgstad, A. K., Halse, J., Bakke, S. J., Lancranjan, I., Marbach, P., Bruns, C., & Jervell, J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.1.3572 · Cited by 176 · see citing works

Long Term Effect of Incremental Doses of the Somatostatin Analog SMS 201–995 in 58 Acromegalic Patients*

SASSOLAS, G., Harris, A. G., James-Deidier, A., & THE FRENCH SMS 201–995≌ACROMEGALY STUDY GROUP† (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-2-391 · Cited by 136 · see citing works

Acromegaly

Colao, A. A. L. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.9.2777 · Cited by 133 · see citing works

The Insulin Resistance of Acromegaly: Evidence for Two Alterations in the Insulin Receptor on Circulating Monocytes

Muggeo, M., Bar, R. S., Roth, J., Kahn, C. R., & Görden, P. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-48-1-17 · Cited by 132 · see citing works

Correlative studies of growth hormone and insulin plasma concentrations with metabolic abnormalities in acromegaly.

Beck, P. A., Schalch, P., Parker, M. L., KIPNIS, D. M., & Daughaday, W. H. (1965) · PubMed · Cited by 131 · see citing works

Successful Treatment of Acromegaly: Metabolic and Clinical Studies in 145 Patients

Lawrence, J. H., Tobias, C. A., Linfoot, J. A., BORN, J. L., Lyman, J. T., Chong, C. Y. L., Manougian, E., & Wei, W. (1970) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-31-2-180 · Cited by 116 · see citing works

Acute Metabolic Effects of Human Growth Hormone

Fineberg, S. E., & Merimee, T. J. (1974) · Diabetes · doi:10.2337/diab.23.6.499 · Cited by 101 · see citing works

Serum lipids in acromegaly

Nikkilä, E. A., & Pelkonen, R. (1975) · Metabolism · doi:10.1016/0026-0495(75)90129-8 · Cited by 96 · see citing works

A Comparison of the Effects of Pegvisomant and Octreotide on Glucose, Insulin, Gastrin, Cholecystokinin, and Pancreatic Polypeptide Responses to Oral Glucose and a Standard Mixed Meal

Parkinson, C., Drake, W. M., Roberts, M. E., Meeran, K. M., BESSER, G. M., & Trainer, P. J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.4.8432 · Cited by 90 · see citing works

Acromegaly

Colao, A. A. L., Merola, B., Ferone, D., & Lombardi, G. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.9.4257 · Cited by 81 · see citing works

Peripheral Glucose Metabolism in Acromegaly

Foss, M. C., SAAD, M. J. A., Paccola, G. M. G. F., de Paula, F. J. A., Piccinato, C. E., & Moreira, A. C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-5-1048 · Cited by 80 · see citing works

Effects of treatment with octreotide in acromegalic patients—a multicenter Italian study

Arosio, M., Macchelli, S., Rossi, C. M., Casati, G., Biella, O., & Faglia, G. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1330430 · Cited by 79 · see citing works

Effect of octreotide on glucose tolerance in acromegaly

Koop, B. L., Harris, A. G., & Ezzat, S. (1994) · European Journal of Endocrinology · doi:10.1530/eje.0.1300581 · Cited by 75 · see citing works

Insulin-like growth factor-binding protein-1: A role in glucose counterregulation?

LEWITT, M. S., & Baxter, R. C. (1991) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(91)90086-8 · Cited by 70 · see citing works

Impact of octreotide, a long‐acting somatostatin analogue, on glucose tolerance and insulin sensitivity in acromegaly

Ho, K. K. Y., Jenkins, A. B., Furler, S. M., Borkman, M., & Chisholm, D. J. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb01443.x · Cited by 68 · see citing works

LDL subfractions in acromegaly: relation to growth hormone and insulin-like growth factor-I

Tan, K. C. B., Shiu, S. W. M., Janus, E. D., & Lam, K. S. L. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)06015-7 · Cited by 58 · see citing works

Growth Hormone-induced Diabetes and High Levels of Serum Insulin in Dogs

Campbell, J. E., & Rastogi, K. S. (1966) · Diabetes · doi:10.2337/diab.15.1.30 · Cited by 57 · see citing works

Octreotide stimulates insulin-like growth factor-binding protein-1: a potential pituitary-independent mechanism for drug action

Ezzat, S., Ren, S. G., Braunstein, G. D., & Melmed, S. K. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.6.1281485 · Cited by 55 · see citing works

LDL physical properties, lipoprotein and Lp(a) levels in acromegalic patients. Effects of octreotide therapy

Arosio, M., Sartore, G., Rossi, C. M., Casati, G., Faglia, G., & Manzato, E. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00426-8 · Cited by 55 · see citing works

Anomalies of lipoprotein pattern and fibrinolysis in acromegalic patients: Relation to growth hormone levels and insulin-like growth factor I

Wildbrett, J., Markolf Hanefeld, E., Fücker, K., Pinzer, T., Bergmann, S., Siegert, G., & Breidert, M. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1211774 · Cited by 48 · see citing works

Serum leptin levels during recombinant human GH therapy in adults with GH deficiency

Janssen, Y. J. H., Frölich, M. A., Deurenberg, P., & Roelfsema, F. (1997) · European Journal of Endocrinology · doi:10.1530/eje.0.1370650 · Cited by 47 · see citing works

The incidence and pathogenesis of hyperlipidaemia in 16 consecutive acromegalic patients

Takeda, R., Tatami, R., Ueda, K., Sagara, H., Nakabayashi, H., & Mabuchi, H. (1982) · European Journal of Endocrinology · doi:10.1530/acta.0.1000358 · Cited by 44 · see citing works

GLUCOSE TOLERANCE AND PLASMA IMMUNOREACTIVE INSULIN LEVELS IN ACROMEGALICS BEFORE AND AFTER SELECTIVE TRANSSPHENOIDAL SURGERY

Roelfsema, F., & Frölich, M. (1985) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1985.tb00153.x · Cited by 44 · see citing works

The role of leptin in reproduction: experimental and clinical aspects

Baldelli, R., Diéguez, C., & Casanueva, F. F. (2002) · Annals of Medicine · doi:10.1080/078538902317338599 · Cited by 43 · see citing works

Serum Leptin Levels in Patients with Acromegaly before and after Correction of Hypersomatotropism by Trans-Sphenoidal Surgery

Damjanovic, S. S., Petakov, M. S., Raic̆ević, S., Micić, D., Marinković, J., Diéguez, C., Casanueva, F. F., & POPOVIC, V. M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6296 · Cited by 42 · see citing works

Serum apolipoprotein(a) correlates with growth hormone levels in Chinese patients with acromegaly

LAM, K., Pang, R. W. C., Janus, E. D., Kung, A. W. C., & Wang, C. C. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90189-2 · Cited by 33 · see citing works

THE INFLUENCE OF BROMOCRIPTINE ON SERUM LEVELS OF GROWTH HORMONE AND OTHER PITUITARY HORMONES AND ITS METABOLIC EFFECTS IN ACTIVE ACROMEGALY

Roelfsema, F., Goslings, B. M., Frölich, M. A., Moolenaar, A. J., van Seters, A. P., & van Slooten, H. (1979) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1979.tb03069.x · Cited by 31 · see citing works

Effects of acromegaly treatment and growth hormone on adipose tissue lipoprotein lipase

Simsolo, R. B., Ezzat, S., Ong, J. M., Saghizadeh, M., & Kern, P. A. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.11.7593431 · Cited by 26 · see citing works

Insulin-like growth factor-I decreases serum lipoprotein(a) during long-term treatment of patients with Laron syndrome

Laron, Z., Wang, X. L., Klinger, B., Silbergeld, A., & Wilcken, D. E. L. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90245-0 · Cited by 26 · see citing works

RESPONSE OF ACROMEGALY TO LONG TERM BROMOCRIPTINE THERAPY: A BIOCHEMICAL AND CLINICAL ASSESSMENT

Clayton, R. N., Vrionides, Y., LYNCH, S. S., BUTT, W. R., & London, D. R. (1978) · European Journal of Endocrinology · doi:10.1530/acta.0.0890469 · Cited by 24 · see citing works

Lipoprotein(a) in Acromegaly

Maffei, P., Sicolo, N., & Plebani, M. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00021 · Cited by 23 · see citing works

Clinical aspects during therapy with the serotonin antagonist ketanserin.

Jap, T. S., & Ho, L. T. (1990) · PubMed · Cited by 21 · see citing works

A Patient with Acromegaly Who Showed Remarkable Improvement of Hyperglycemia after Treatment with Octreotide.

Hirose, T., Kuroda, T., Otsuki, M., Takagi, M., Yamamoto, H., Motomura, T., Kurebayashi, S., Miyashita, Y., Masafumi, K. O. G. A., Arita, N., et al. (1997) · Internal Medicine · doi:10.2169/internalmedicine.36.345 · Cited by 11 · see citing works

Divergent Effects of Octreotide on Glucose Tolerance in Patients with Acromegaly

Hizuka, N. (1997) · Internal Medicine · doi:10.2169/internalmedicine.36.319 · Cited by 5 · see citing works

Hyperproinsulinaemia in Acromegaly: Evidence for Abnormal Pancreatic β-Cell Function?

Gama, R. M., Teale, J. D., Wright, J., Ferns, G. A., & Marks, V. (1997) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329703400605 · Cited by 5 · see citing works

Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline

Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., Sacks, F., Murad, M. H., & Stalenhoef, A. F. H. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3213 · Cited by 887 · see citing works

Increase of Classic and Nonclassic Cardiovascular Risk Factors in Patients with Acromegaly

Vilar, L., Naves, L. A., Costa, S. S., Abdalla, L. F., Coelho, C. E., & Casulari, L. A. (2007) · Endocrine Practice · doi:10.4158/ep.13.4.363 · Cited by 63 · see citing works

Clinical-Biochemical Correlations in Acromegaly at Diagnosis and the Real Prevalence of Biochemically Discordant Disease

Mercado, M., Monteros, A. L. E. D. L., Sosa, E., Cheng, S., Mendoza, V., Hernández, I., Sandoval, C., Guinto, G., & Molina, M. (2004) · Hormone Research in Paediatrics · doi:10.1159/000082032 · Cited by 55 · see citing works

Treatment options for hypertriglyceridemia: From risk reduction to pancreatitis

Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., & Stalenhoef, A. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.10.002 · Cited by 50 · see citing works

Diagnóstico e tratamento da acromegalia no Brasil

Donangelo, I., Une, K. N., & Gadelha, M. R. (2003) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302003000400006 · Cited by 22 · see citing works

Avaliação do metabolismo da glicose em pacientes acromegálicos antes e após tratamento com octreotide LAR

Corrêa, L. L., Taboada, G. F., van Haute, F. R., Casini, A. F., Lima, G. A. B., Neto, L. V., Machado, E. D. O., Fontes, R. G., de Andrade, C. C., Schrank, Y., et al. (2008) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302008000100009 · Cited by 12 · see citing works

Hipertrigliceridemias secundarias

Viñals, C., Zambón, D., Yago, G., Doménech, M., & Ortega, E. (2021) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2021.02.006 · Cited by 11 · see citing works

An Unusual Cause of Hypertriglyceridemic Acute Pancreatitis

Resheq, Y. J., Rinninger, F., Lohse, A. W., & Schramm, C. (2012) · The American Journal of Gastroenterology · doi:10.1038/ajg.2012.57 · Cited by 4 · see citing works

Freqüência de fatores de risco cardiovascular clássicos e não-clássicos em portadores de acromegalia

Filho, R., & Vilar, L. (2007)

Diabetes Complicating Acromegaly and Pituitrin-Insulin Antagonism

Watson-Wemyss, H. L. (1927) · PubMed Central · Cited by 3 · see citing works

Diabetic lipemia in acromegaly.

Hajjar, E. T., Shediac, C. C., & Salti, I. S. (1973) · PubMed

[Acromegaly and diabetes].

Fj, G. C. (1952) · PubMed · Cited by 3 · see citing works

[Diabetes mellitus in acromegaly].

Treml, E. (1950) · PubMed

[Diabetes in acromegaly; 3 personal cases].

Decourt, J., Berthaux, P., & Civatte, J. (1950) · PubMed